Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems

March 29, 2011 By Bio-Medicine.Org

WALTHAM, Mass., March 29, 2011 /PRNewswire/ — MicroCHIPS, Inc.,
a developer of innovative drug delivery devices and biosensors,
today announced that the U.S. Patent Office and Trademark Office
has granted U.S. Patent No. 7,892,221, Method of Controlled Drug
Delivery from Implant Device. This patent in conjunction with U.S.
Patent No. 7,070,590 provides broad coverage for the design and
fabrication of reservoir-based medical devices used for implantable
drug delivery systems.

MicroCHIPS’ intellectual property originated as patent filings
at the Massachusetts Institute of Technology, by professors and
MicroCHIPS cofounders Robert Langer and Michael Cima, and cofounder
John Santini. These patents are licensed to MicroCHIPS, which has
continued to develop and enhance the reservoir-based technology and
to generate additional intellectual property covering
microreservoirs, controlled release components and systems, and
biosensors. As a result, MicroCHIPS’ current patent portfolio
includes more than 80 patents and more than 50 pending
applications, covering the U.S., Canada, various countries in
Europe and Asia, as well as Australia.

“The granting of this patent provides the fundamental building
blocks for programmable medical drug delivery implants to address
various diseases such as diabetes, osteoporosis, heart disease, and
cancer,” said Robert Langer, ScD, Institute Professor at the David
H. Koch Institute for Integrative Cancer Research at MIT.

MicroCHIPS’ miniaturized systems are adaptable to implants and
catheters as well as on-body delivery systems, external pumps, pens
and infusion systems. Currently, the MicroCHIPS technology is
embodied in the company’s medical implants that are part of a
clinical trial to treat osteoporosis in women. The trial is
evaluating the pharmacokinetics of precise delivery of human
parathyroid hormone (hPTH 1-34) from a programmable, wireless
implanted device.

“This patent and technology portfolio combin

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech